Mechanistically, PDIK1L may stabilize oncogenic signaling by modulating DNA repair or metabolic adaptations, akin to OTUD6A, a deubiquitinase recently shown to stabilize c-Myc and promote metabolic remodeling in prostate cancer (Peng et al., 2022). The gene discussed is OTUD6A; the disease is prostate carcinoma.